Apoptotic Induction in Transformed Follicular Lymphoma Cells by Bcl-2 Downregulation

References

• Nuñez G., London L., Hockenbery D., Alexander M., McKearn J., Korsmeyer S.J. Deregulated BCL-2 gene expression selectively prolongs survival of growth factors-deprived hemopoietic cell lines. Journal of Immunology. 1990; 144: 3602–3610
   PubMed Web of Science ®Google Scholar
• Reed J.C. Bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematology Oncology Clinics of North America 1995; 9: 451–473
   PubMed Web of Science ®Google Scholar
• Hockenbery D., Nuñez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334–336
   PubMed Web of Science ®Google Scholar
• McDonnell T.J., Deane N., Piatt F.M., Nuñez G., Jaeger U., McKearn J.P., Korsmeyer S.J. Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989; 57: 79–88
   PubMed Web of Science ®Google Scholar
• McDonnell T.J., Korsmeyer S.J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991; 349: 254–256
   PubMed Web of Science ®Google Scholar
• Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo, with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993; 74: 609–619
   PubMed Web of Science ®Google Scholar
• Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nuñez G., Thompson C.B. BCL-X, a BCL-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597–608
   PubMed Web of Science ®Google Scholar
• Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285–291
   PubMed Web of Science ®Google Scholar
• Chittenden T., Harrington E.A., O'Connor R., Flemington C., Lutz R.J., Evans G.I., Guild B.C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995; 374: 733–736
   PubMed Web of Science ®Google Scholar
• Kiefer M.C., Brauer M.J., Powers V.C., Wu J.J., Umansky S.R., Tomel L.D., Barr P.J. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995; 374: 736–739
   PubMed Web of Science ®Google Scholar
• Kozopas K.M., Yang T., Buchan H.L., Zhou P., Craig R.W. MCL-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL-2. Proceedings of National Academy of Sciences USA 1993; 90: 3516–3520
   PubMed Web of Science ®Google Scholar
• Lin E.Y., Orlofsky A., Berger M.S., Prystowsky M.B. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to BCL-2. Journal of Immunology. 1993; 151: 1979–1988
   PubMed Web of Science ®Google Scholar
• Pearson G.R., Luka J., Petti L., Sample J., Birkenback M., Braun D., Kieff E. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 1987; 160: 151–161
   PubMed Web of Science ®Google Scholar
• Neilan J.G., Lu Z., Afonso C.L., Kutish G.F., Sussman M.D., Rock D.L. An African Swine fever virus with similarity to the protooncogene BCL-2 and the Epstein-Barr virus gene BHRF1. Journal of Virology 1993; 67: 4391–4394
   PubMed Web of Science ®Google Scholar
• Sato T., Hanada M., Bodrug S., Irie S., Iwama N., Boise L., Thompson C., Fong L., Golemis E., Wang H.G., Reed J.C. Interactions among members of bcl-2 protein analyzed with a yeast two-hybrid system. Proceedings of National Academy of Sciences USA 1994; 91: 9238–9242
   PubMed Web of Science ®Google Scholar
• Yin X.-M., Oltvai Z.N., Korsmeyer S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994; 369: 321–323
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Gorham J., Cossman J., Jaffe E., Croce C.M. The t(14;18) chromosome translocation involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 229: 1390–1393
   PubMed Web of Science ®Google Scholar
• Graninger W.B., Seto M., Boutain B., Goldman P., Korsmeyer S.J. Expression of bcl-2 and bcl-2-lg fusion transcripts in normal and neoplastic cells. Journal of Clinical Investigations 1987; 80: 1512–1515
   PubMed Web of Science ®Google Scholar
• Bakhshi A., Jensen J.P., Goldman P., Wright J.J., McBride C.W., Epstein A.L., Korsmeyer S.J. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899–906
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Ikegaki N., Croce C.M. Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene 1987; 2: 3–7
   PubMed Web of Science ®Google Scholar
• Tari A.M., Tucker S.D., Deisseroth A., Lopez-Berestein G. Liposomal delivery of methylphospho-nate oligodeoxynucleotides in chronic myelogenous leukemia. Blood 1994; 84: 601–607
   PubMed Web of Science ®Google Scholar
• Tari A.M., Neamati N., Andreeff M., Lopez-Berestein G. Liposomal delivery of P-ethoxy antisense oligodeoxynucleotides in chronic myelogenous leukemia. Targeting of Drugs: Strategies for oligonucleotide and gene delivery in therapy, G. Gregoriadis. Plenum Press, in press
   Google Scholar
• Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B., Reed J.C. Tumor suppressor. p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799–1805
   PubMed Web of Science ®Google Scholar
• Vaux D., Cory S., Adams J. Bcl-2 promotes hemapoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440–442
   PubMed Web of Science ®Google Scholar
• Reed J.C., Cuddy M., Haldar S., Croce C., Nowell P., Makover D. Bcl-2-mediated tumorigenicity in a human T-lymphoid cell line: synergy with c-myc and inhibition by Bcl-2 antisense. Proceedings of National Academy of Sciences USA 1990; 87: 3660–3664
   PubMed Web of Science ®Google Scholar
• Blagosklonny M.V., Neckers L. The role of Bcl-2 protein and autocrine growth factors in a human follicular lym-phoma-derived B cell line. European Cytokine Network 1995; 6: 21–27
   PubMed Web of Science ®Google Scholar
• Cotter F.E., Cj P., Hall P., Pocock C., Al Mahdi N., Cowell J.K., Morgan G. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. Oncogene 1994; 9: 3049–3055
   PubMed Web of Science ®Google Scholar
• Sedlak T.W., Oltvai Z.N., Yang E., Wang K., Boise L.H., Thompson C.B., Korsmeyer S.J. Multiple bcl-2 family members demonstrate selective dimerization with bax. Proceedings of National Academy of Sciences USA 1995; 92: 7834–7838
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Kinzler K.W. p53 function and dysfunction. Cell 1992; 70: 523–526
   PubMed Web of Science ®Google Scholar
• Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human BAX gene. Cell 1995; 80: 293–299
   PubMed Web of Science ®Google Scholar
• Fukuchi K., Tomoyasu S., Watanabe H., Kaetsu S., Tsuruoka N., Gomi K. Iron deprivation results in an increase in p53 expression. Biological Chemistry Hoppe-Seyler 1995; 376: 627–630
   PubMed Web of Science ®Google Scholar
• Kitada S., Takayama S., De Riel K., Tamaka S., Reed J.C. Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Research and Development 1994; 4: 71–79
   PubMedGoogle Scholar